Net Deals Web Search

Search results

1. Results From The WOW.Com Content Network

2. Culper Research discloses short position in Acadia Pharma - AOL

   www.aol.com/news/culper-research-discloses-short...

   Acadia has an antipsychotic drug sold under the brand name Nuplazid approved for patients with a type of Parkinson's disease. The company's shares clawed back some lost ground and were last down 2.1%.

3. Acadia to stop trials of antipsychotic drug after it fails ...

   www.aol.com/news/acadia-pharmaceuticals...

   (Reuters) -Acadia Pharmaceuticals said on Monday it does not plan to conduct further clinical trials of its antipsychotic drug, pimavanserin, after it failed to improve negative symptoms of ...

4. Acadia (ACAD) Up More Than 20% in Past 3 Months: Here's Why - AOL

   www.aol.com/news/acadia-acad-more-20-past...

   Acadia's (ACAD) Nuplazid, approved for treating hallucinations and delusions associated with Parkinson's disease psychosis, has seen strong uptake so far. Its label expansion studies also hold ...

5. Acadia Pharmaceuticals - Wikipedia

   en.wikipedia.org/wiki/Acadia_Pharmaceuticals

   Total equity. US$699.14 million (2019) Number of employees. 570 (June 30, 2020) Website. acadia .com. Footnotes / references. [1] Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Sorrento Valley, San Diego, California.

6. Acadia Pharmaceuticals (ACAD) Reports Q3 Loss, Misses ... - AOL

   www.aol.com/news/acadia-pharmaceuticals-acad...

   Acadia (ACAD) delivered earnings and revenue surprises of 5.56% and 6.40%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

7. Hedge Funds Are Betting On ACADIA Pharmaceuticals Inc ... - AOL

   www.aol.com/news/hedge-funds-betting-acadia...

   For premium support please call: 800-290-4726 more ways to reach us

8. Q2 Earnings Preview For ACADIA Pharmaceuticals - AOL

   www.aol.com/news/q2-earnings-preview-acadia...

   On Wednesday, ACADIA Pharmaceuticals (NASDAQ: ACAD ) will release its latest earnings report. Here is Benzinga's outlook for the company. Earnings and Revenue ACADIA Pharmaceuticals EPS will ...

9. Hedge Funds Aren’t Crazy About ACADIA Pharmaceuticals ... - AOL

   www.aol.com/news/hedge-funds-aren-t-crazy...

   In this article you are going to find out whether hedge funds think ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is a good investment right now. We like to check what the smart money thinks first ...